Australia markets closed

Calliditas Therapeutics AB (publ) (CALT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
20.05+0.15 (+0.75%)
As of 09:30AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3323
Avg. Estimate-0.14-0.060.022.64
Low estimate-0.2-0.14-0.040.94
High estimate-0.110.030.085.42
Year ago EPS-0.67-0.32-1.640.02
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4444
Avg. Estimate34.64M40.9M179.59M324.21M
Low estimate32.56M38.92M172.15M273.96M
High estimate38.12M44.18M186.58M443.01M
Year ago sales18.34MN/A113.81M179.59M
Sales growth (year/est)88.90%N/A57.80%80.50%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.38-0.17-0.31-0.07
Actual EPS-0.67-0.32-0.58-0.06
Difference-0.29-0.15-0.270.01
Surprise %-76.30%-88.20%-87.10%14.30%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.14-0.060.022.64
7 days ago-0.14-0.060.022.63
30 days ago-0.15-0.060.022.65
60 days ago-0.15-0.060.022.68
90 days ago-0.08-0.032.23.18
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCALTIndustrySector(s)S&P 500
Current qtr.79.10%N/AN/AN/A
Next qtr.81.20%N/AN/AN/A
Current year101.20%N/AN/AN/A
Next year13,100.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A